Εμφανίζονται 1 - 16 Αποτελέσματα από 16 για την αναζήτηση '"малатион"', χρόνος αναζήτησης: 0,65δλ Περιορισμός αποτελεσμάτων
  1. 1
    Academic Journal
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
    Dissertation/ Thesis
  9. 9
    Academic Journal

    Συγγραφείς: G. M. Calaf

    Πηγή: Siberian journal of oncology; Том 17, № 4 (2018); 5-13 ; Сибирский онкологический журнал; Том 17, № 4 (2018); 5-13 ; 2312-3168 ; 1814-4861 ; 10.21294/1814-4861-2018-17-4

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.siboncoj.ru/jour/article/view/809/547; https://www.siboncoj.ru/jour/article/downloadSuppFile/809/1052; https://www.siboncoj.ru/jour/article/downloadSuppFile/809/1053; https://www.siboncoj.ru/jour/article/downloadSuppFile/809/1054; https://www.siboncoj.ru/jour/article/downloadSuppFile/809/1055; https://www.siboncoj.ru/jour/article/downloadSuppFile/809/1056; Perera F.P. Environment and cancer: who are susceptible? Science. 1997; 278(5340): 1068-1073.; Cabello G., Valenzuela M., Vilaxa A., Duran V., Rudolph I., Hrepic N., Calaf G. A rat mammary tumor model induced by the organophosphorous pesticides parathion and malathion, possibly through acetylcholinesterase inhibition. Environ Health Perspect. 2001 May; 109(5): 4719.; Knower K.C., To S.Q., Leung Y.K., Ho S.M., Clyne C.D. Endocrine disruption of the epigenome: a breast cancer link. Endocr Relat Cancer. 2014 Mar 12; 21(2): T3355. doi:10.1530/ERC-13-0513.; IARC. IARC working group on the evaluation of carcinogenic risksto humans. IARC Monogr Eval Carcinog Risks Hum. 1994; 61: 45119.; Guyton K.Z., Loomis D., Grosse Y., El Ghissassi F., Benbrahim-Tallaa L., Guha N., Scoccianti C., Mattock H., Straif K.; International Agency for Research on Cancer Monograph Working Group, IARC, Lyon, France. Carcinogenicity of tetrachlorvinphos, parathion, malathion, diazinon, and glyphosate. Lancet Oncol. 2015 May; 16(5): 4901. doi:10.1016/S1470-2045(15)70134-8.; Calaf G.M., Roy D. Human drug metabolism genes in parathion-and estrogen-treated breast cells. Int J Mol Med. 2007; 20(6): 875881.7; Falck F.Jr., Ricci A.Jr., Wolff M.S., Godbold J., Deckers P. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health. 1992 Mar-Apr; 47(2): 1436.; Wolff M.S., Toniolo P.G., Lee E.W., Rivera M., Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst. 1993; 85(8): 648652.; Zham S.H., Ward M.H., Blair A. Pesticides and cancer. Occupational Medicine: State of the Art Reviews. Philadelphia, PA: Hanley and Belfus Inc., 1997; 269289.; Blair A., Dosemeci M., Heineman E.F. Cancer and other causes of death among male and female farmers from twenty-three states. Am J Ind Med. 1993; 23(5): 729742.; McDuffie H.H. Women at work: agriculture and pesticides. J Occup Med. 1994 Nov; 36(11): 12406.; Calaf G.M., Garrido F. Catechol estrogens as biomarkers for mammary gland cancer. Int J Oncol. 2011 Jul; 39(1): 17783. doi:10.3892/ijo.2011.1008.; Calaf G.M., Echiburu-Chau C. Synergistic effect of malathion and estrogen on mammary gland carcinogenesis. Oncol Rep. 2012 Aug; 28(2): 6406. doi:10.3892/or.2012.1817.; Russo J., Russo I.H. Mammary tumorigenesis. Prog Exp Tumor Res 1991; 33: 175191.; Wellings S.R., Jensen H.M., Marcum R.G. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst. 1975; 55(2): 231273.; Aznar S., Lacal J.C. Rho signals to cell growth and apoptosis. Cancer Lett. 2001; 165(1): 110.; Schmitz A.A., Govek E.E., Bottner B., Van Aelst L. Rho GTPases: signaling, migration, and invasion. Exp Cell Res. 2000 Nov 25; 261(1): 112. doi:10.1006/excr.2000.5049.; Field J.K., Spandidos D.A. The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis (review). Anticancer Res. 1990; 10(1): 122.; Sato T., Akiyama F., Sakamoto G., Kasumi F., Nakamura Y. Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res. 1991; 51(21): 57945799.; Benz C.C., Scott G.K., Santos G.F., Smith H.S. Expression of c-myc, c-Ha-ras1, and c-erbB-2 proto-oncogenes in normal and malignant human breast epithelial cells. J Natl Cancer Inst. 1989 Nov 15; 81(22): 17049.; Frame M.C., Brunton V.G. Advances in Rho-dependent actin regulation and oncogenic transformation. Curr Opin Genet Dev. 2002; 12(1): 3643.; Price L.S., Collard J.G. Regulation of the cytoskeleton by Rhofamily GTPases: implications for tumour cell invasion. Semin Cancer Biol. 2001; 11(2): 167173. doi:10.1006/scbi.2000.0367.; Denoyelle C., Hong L., Vannier J.P., Soria J., Soria C. New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and - independent effects. Br J Cancer. 2003 May 19; 88(10): 163140. doi:10.1038/sj.bjc.6600925.; Sahai E., Marshall C.J. RHO-GTPases and cancer. Nat Rev Cancer. 2002; 2(2): 133142. doi:10.1038/nrc725.; Fritz G., Just I., Kaina B. Rho GTPases are over-expressed in human tumors. Int J Cancer. 1999; 81(5): 682687.; Hulpiau P., van Roy F. Molecular evolution of the cadherin superfamily. Int J Biochem Cell Biol. 2009 Feb; 41(2): 34969. doi:10.1016/j.biocel.2008.09.027.; Gumbiner B.M. Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol. 2005 Aug; 6(8): 62234.; Tepass U. Genetic analysis of cadherin function in animal morphogenesis. Curr Opin Cell Biol. 1999; 11(5): 540548.; Wheelock M.J., Jensen P.J. Regulation of keratinocyte intercellular junction organization and epidermal morphogenesis by E-cadherin. J Cell Biol. 1992 Apr; 117(2): 41525.; Jeanes A., Gottardi C.J., Yap A.S. Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene. 2008 Nov 24; 27(55): 69209. doi:10.1038/onc.2008.343.; Shapiro L., Weis W.I. Structure and biochemistry of cadherins and catenins. Cold Spring Harb Perspect Biol. 2009 Sep; 1(3): a003053. doi:10.1101/cshperspect.a003053.; Perez-Moreno M., Fuchs E. Catenins: keeping cells from getting their signals crossed. Dev Cell. 2006; 11(5): 601612.; Duprey P., Paulin D. What can be learned from intermediate filament gene regulation in the mouse embryo. Int J Dev Biol. 1995; 39(3): 443457.; Stewart M. Intermediate filament structure and assembly. Curr Opin Cell Biol. 1993; 5(1): 311.; Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press, 1996. 128.; Lacassagne A.L. Apparition de cancers de la mamelle chez la souris mâle soumiseàdes injections de folliculine. Compt Rend Acad Sci. 1932; 195: 630632.; De Mascarel I., MacGrogan G. Management of breast epithelial atypia. Ann Pathol. 2007; 27(3): 182194.; Spandidos D.A., Yiagnisis M., Papadimitriou K., Field J.K. ras, c-myc and c-erbB-2 oncoproteins in human breast cancer. Anticancer Res. 1989; 9(5): 13851393.; Giltnane J.M., Balko J.M. Rationale for targeting the Ras/MAPK pathway in triple- negative breast cancer. Discov Med. 2014; 17(95): 275283.; Calaf G.M., Abarca-Quinones J. Ras protein expression as a marker for breast cancer. Oncol Lett. 2016; 11(6): 36373642. doi:10.3892/ol.2016.4461.; Malumbres M., Barbacid M. RAS oncogenes: the first 30 years. Nat Rev Cancer. 2003 Jun; 3(6): 45965. doi:10.1038/nrc1097. doi:10.1038/nrc1097.; Spandidos D.A., Agnantis N.J. Human malignant tumours of the breast, as compared to their respective normal tissue, have elevated expression of the Harvey ras oncogene. Anticancer Res. 1984; 4(45): 269272.; Agnantis N.J., Parissi P., Anagnostakis D., Spandidos D.A. Comparative study of Harvey-ras oncogene expression with conventional clinicopathologic parameters of breast cancer. Oncology. 1986; 43(1): 3639. doi:10.1159/000226101.; Agnantis N.J., Petraki C., Markoulatos P., Spandidos D.A. Immunohistochemical study of the ras oncogene expression in human breast lesions. Anticancer Res. 1986; 6(5): 11571160.; Efremidis A.P., Agnantis N.J., Patra F., Papadopoulou C., Spandidos D.A. Clinical significance of elevated p21 ras oncogene expression in breast cancer patients. Cancer J. 1989; 2(9): 288291.; Candlish W., Kerr I.B., Simpson H.W. Immunocytochemical demonstration and significance of p21 ras family oncogene product in benign and malignant breast disease. J Pathol. 1986; 150(3): 163167. doi:10.1002/path.1711500303.; Going J.J., Anderson T.J., Wyllie A.H. Ras p21 in breast tissue: associations with pathology and cellular localisation. Br J Cancer 1992; 65(1): 4550.; Gilles C., Polette M., Zahm J.M., Tournier J.M., Volders L., Foidart J.M., Birembaut P. Vimentin contributes to human mammary epithelial cell migration. J Cell Sci. 1999; 112 (Pt 24): 46154625.; Calaf G.M., Balajee A.S., Montalvo-Villagra M.T., Leon M., Daniela N.M., Alvarez R.G., Roy D., Narayan G., Abarca-Quinones J. Vimentin and Notch as biomarkers for breast cancer progression. Oncol Lett. 2014; 7(3): 721727. doi:10.3892/ol.2014.1781.; https://www.siboncoj.ru/jour/article/view/809

  10. 10
  11. 11
  12. 12

    Συνεισφορές: Томский государственный университет Химический факультет Кафедра аналитической химии, Томский государственный университет Сибирский физико-технический институт Научные подразделения СФТИ, Томский государственный университет Химический факультет Кафедра органической химии

    Πηγή: Полифункциональные химические материалы и технологии : материалы Международной научной конференции, 21-22 мая 2015 г. Томск, 2015. Т. 3. С. 223-226

    Περιγραφή αρχείου: application/pdf

  13. 13
  14. 14
  15. 15
  16. 16